Morocco vs Small island developing states (SIDS): Proportion of the target population who received
Morocco
98.0%
in 2024
Small island developing states (SIDS)
63.0%
in 2024
Morocco rank
14th
Small island developing states (SIDS) rank
16th
Proportion of the target population who received over time
- Morocco
- Small island developing states (SIDS)
How they compare
Morocco currently reports 98.0% against 63.0% in Small island developing states (SIDS), a difference of 35.0%.
That makes Morocco's figure about 1.6 times Small island developing states (SIDS)'s.
Across all 15 years both countries report, Morocco has been ahead every year.
Morocco ranks 14th and Small island developing states (SIDS) ranks 16th of 165 countries.
Morocco has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Morocco | Small island developing states (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.8% | 23.8% | 68.0% | Morocco |
| 2010s | 90.8% | 35.3% | 55.5% | Morocco |
| 2020s | 98.4% | 56.8% | 41.6% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Morocco or Small island developing states (SIDS)?
- Morocco, at 98.0% against 63.0% in Small island developing states (SIDS) as of 2024.
- What is the difference in proportion of the target population who received between Morocco and Small island developing states (SIDS)?
- 35.0%, with Morocco ahead.
- How many years of comparable data are there for Morocco and Small island developing states (SIDS)?
- 15 years are reported by both, from 2004 to 2024.
- How do Morocco and Small island developing states (SIDS) rank globally for proportion of the target population who received?
- Morocco ranks 14th and Small island developing states (SIDS) ranks 16th of 165 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.